ReviewCancer control : journal of the Moffitt Cancer Center

Quality of Life Measurement in PARP Inhibitor Trials of Epithelial Ovarian Cancer - What Do We Know?

Sarita Kumari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.